Reference | Cohort/study name | Country of study | LE in HIV-positive population | LE in general population |
---|---|---|---|---|
Nakagawa et al. [8] | Computer simulation (HIV Synthesis) | UK | LE at birth: 75.0Â years if diagnosed with HIV with high CD4 count; 71.5Â years if diagnosed with HIV with low CD4 count | LE at birth: estimated from model to be 82.0Â years if not infected with HIV |
The Antiretroviral Therapy Cohort Collaboration [9] | ART-CC | Multi-country study (Europe and North America) | LE at age 20: 43.1Â years. LE at age 35: 31.7Â years | Not stated |
Johnson et al. [10] | IeDEA-SA | South Africa | LE at age 20: 27.6Â years in men; 36.8Â years in women. LE at age 60: 10.1Â years in men; 14.4Â years in women | Not stated |
Mills et al. [11] | The AIDS Support Organization (TASO) cohort | Uganda | LE at age 20: 26.7Â years. LE at age 35Â years: 27.9Â years | LE at age 20: 41Â years |
Losina et al.[12] | Computer simulation (CEPAC) | USA | LE at age 33: 22.66Â years if optimally diagnosed and treated; 19.36Â years if treated with cART and adherence follows normal patterns | LE at age 33: 42.91Â years for general population; 34.58Â years if risk profile similar to those with HIV |
Bor et al. [17] | Â | KwaZulu-Natal, South Africa | No specific estimates | LE at birth: 52.3Â years in 2000; 49.2Â years in 2003; 60.5Â years in 2011 |
Lohse et al. [21] | Danish HIV Cohort Study | Denmark | LE at age 25: 8Â years in 1995 to 1996; 23Â years in 1997 to 1999; 33Â years in 2000 to 2005 | LE at age 25: 51Â years |
May et al. [23] | UK Collaborative HIV Cohort Study | UK | LE at age 20: 39.5Â years in men; 50.2Â years in women. LE at age 35: 30.1Â years in men; 37.7Â years in women | LE at age 20: 57.8Â years in men; 61.6Â years in women. LE at age 35: 43.5Â years in men; 46.9Â years in women |
van Sighem et al. [41] | ATHENA Cohort | The Netherlands | LE at age 25: 52.7Â years in men; 57.8Â years in women | LE at age 25: 53.1Â years in men; 58.1Â years in women |